600329.SHG Tianjin Zhongxin Pharmaceutical Group Corp Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
57.41 CNY
Close of Nov 5, 2026
33.83 50.95
Market cap
CNY 32.7B
P/E
37.0x
P/B
5.32x
ROE
19.7%
Dividend yield
3.00%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600329.SHG undervalued?

Graham number
Price57.41
Graham value19.43
Premium195.5%

600329.SHG trades 195.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd fundamental analysis

No fundamental analysis for Tianjin Zhongxin Pharmaceutical Group Corp Ltd yet.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Tianjin Zhongxin Pharmaceutical Group Corp Ltd

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was …

Full company profile